531 MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results

2015 ◽  
Vol 51 ◽  
pp. S114 ◽  
Author(s):  
D. Migliorini ◽  
R. Vernet ◽  
M.C. Belkouch ◽  
P. Luy ◽  
S. Blaser ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Clinical Outcome ◽  
Phase I ◽  
Tumor Cells ◽  
Phase I Clinical Trial ◽  
Autologous Tumor ◽  
Cell Technology

scholarly journals A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

Oncotarget ◽  
2015 ◽  
Vol 6 (38) ◽  
pp. 41339-41349 ◽  
Author(s):  
Shan-Shan Jiang ◽  
Yan Tang ◽  
Yao-Jun Zhang ◽  
De-Sheng Weng ◽  
Zhong-Guo Zhou ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Phase I ◽  
Tumor Infiltrating Lymphocytes ◽  
Phase I Clinical Trial ◽  
Primary Hepatocellular Carcinoma ◽  
Autologous Tumor ◽  
Infiltrating Lymphocytes

Phase I Clinical Trial of a Genetically Modified and Oncolytic Vaccinia Virus GL-ONC1 in patients with peritoneal carcinomatosis

2012 ◽  
Vol 50 (08) ◽  
Author(s):  
UM Lauer ◽  
M Zimmermann ◽  
U Koppenhöfer ◽  
M Bitzer ◽  
NP Malek ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Vaccinia Virus ◽  
Peritoneal Carcinomatosis ◽  
Genetically Modified ◽  
Phase I Clinical Trial

scholarly journals Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

2021 ◽  
Vol 32 (1) ◽  
pp. 120-121
Author(s):  
S. Hiltbrunner ◽  
C. Britschgi ◽  
P. Schuberth ◽  
L. Bankel ◽  
T.D.L. Nguyen-Kim ◽  
...  
Keyword(s):  
Clinical Trial ◽  
T Cells ◽  
Phase I ◽  
Local Delivery ◽  
Fibroblast Activation Protein ◽  
Phase I Clinical Trial ◽  
Pleural Mesothelioma ◽  
First Report ◽  
Car T Cells ◽  
Car T
Sign in / Sign up

Export Citation Format

Share Document